IRhythm Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 03, 2023 at 01:35 am IST
Share
iRhythm Technologies, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 124.6 million compared to USD 103.88 million a year ago. Net loss was USD 27.12 million compared to USD 21.45 million a year ago. Basic loss per share from continuing operations was USD 0.89 compared to USD 0.71 a year ago. Diluted loss per share from continuing operations was USD 0.89 compared to USD 0.71 a year ago.
For the nine months, sales was USD 360.17 million compared to USD 298.3 million a year ago. Net loss was USD 84.71 million compared to USD 95.96 million a year ago. Basic loss per share from continuing operations was USD 2.78 compared to USD 3.22 a year ago.
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
IRHYTHM TECHNOLOGIES, INC. 
